Bartholomew, Tyler S.
Andraka-Cristou, Barbara
Totaram, Rachel K.
Harris, Shana
Doblecki-Lewis, Susanne
Ostrer, Lily
Serota, David P.
Forrest, David W.
Chueng, Teresa A.
Suarez, Edward
Tookes, Hansel E.
Funding for this research was provided by:
National Institute on Drug Abuse (1 DP2 DA053720–01)
National Institute of Mental Health (3P30MH116867–01A1S1)
National Institute of Allergy and Infectious Diseases (P30AI073961)
National Cancer Center (P30CA240139)
Article History
Received: 27 September 2022
Accepted: 21 November 2022
First Online: 3 December 2022
Declarations
:
: This study was approved by the Institutional Review Board of the University of Miami (IRB #20190963). All participants provided verbal informed consent. Informed consent was obtained from all individual participants included in this study.
: Not applicable.
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: TSB and HET receive research funding from Gilead Sciences.